Dr. Maher Hadaki is a UK-trained Consultant Medical Oncologist at Mediclinic Comprehensive Cancer Centre in Abu Dhabi, with over 10 years of experience as a consultant in the UK. He completed his oncology training at University College Hospital, London, and Addenbrooke’s Teaching Hospital, Cambridge, and is a fellow of the Royal College of Radiologists and a member of the Royal College of Physicians. Dr. Hadaki specializes in the use of radiotherapy for early and advanced cancers, with a particular interest in stereotactic ablative radiotherapy (SABR) and advanced targeted therapies.

He treats all stages of breast cancer and manages a wide range of malignancies, combining chemotherapy, immunotherapy, radiotherapy, biological therapies, and molecular-guided treatments for personalized care. He participates in multidisciplinary team meetings and has access to clinical trials, local ablative therapies, and palliative care services to provide comprehensive cancer management. Dr. Hadaki collaborates with leading surgeons and integrates state-of-the-art technologies, including IMRT, IGRT, and Cyberknife, into his treatment plans.

He is registered with major private medical insurers, including BUPA, AXA, Aviva, and Vitality, and treats both local and international patients. Dr. Hadaki’s practice emphasizes evidence-based, individualized oncology care, combining advanced treatments with holistic patient support.